Sort
326,823 grants matching “clinical trial”
The North American Mitochondrial Disease Consortium (NAMDC)
$1,746,884Michio Hirano · Columbia University Health Sciences · U54 · FY2019 · NS
Wake Forest Alzheimer's Disease Core Center
$1,746,797Suzanne Craft · Wake Forest University Health Sciences · P30 · FY2017 · AG
Wake Forest Alzheimer's Disease Core Center
$1,746,765Suzanne Craft · Wake Forest University Health Sciences · P30 · FY2016 · AG
Commercialization of an Improved Treatment of Extremity Fractures Using a Regenerative Bone Adhesive to Accelerate Bone Healing in Aging Patients
$1,746,739Brian Hess · Revbio, Inc. · SB1 · FY2023 · AG
1/2 Cognitive Behavioral Therapy and Trazodone Effects on Sleep and Blood Pressure in Insomnia Phenotypes Based on Objective Sleep Duration: A Sequential Cohort/Randomized Controlled Trial
$1,746,681Alexandros N Vgontzas · Pennsylvania State Univ Hershey Med Ctr · UH3 · FY2024 · HL
Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Center - Seattle
$1,746,547Jeffrey S Chamberlain · University Of Washington · P50 · FY2023 · AR
Endoscopic versus Shunt Treatment of Hydrocephalus in Infants
$1,746,515John Kestle · University Of Utah · U01 · FY2019 · NS
HIV IMPAACT RELATED STUDIES
$1,746,450Barbara Driver · Westat, Inc. · N01 · FY2020 · HD
COLUMBIA UNIV HLTH SCI CLINICAL AND TRANSLATIONAL SCIENCE AWARD
$1,746,301Henry N Ginsberg · Columbia University Health Sciences · UL1 · FY2010 · RR
New NAPRTCS Trials in Steroid-Free Immunosuppression
$1,746,243Oscar Salvatierra · Stanford University · U01 · FY2006 · AI
NIH Chronic GVHD Study Group
$1,746,196Steven Pavletic · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Bruker scimaX⢠Magnetic Resonance Mass Spectrometer
$1,746,141Peggi M Angel · Medical University Of South Carolina · S10 · FY2021 · OD
Trial to Reduce IDDM in the Genetically at Risk: A Nutritional primary prevention
$1,745,948Dorothy J Becker · University Of Pittsburgh At Pittsburgh · U01 · FY2014 · HD
Core-001
$1,745,835William Robert Taylor · Emory University · UL1 · FY2017 · TR
ACISR for Late-Life Depression Prevention
$1,745,793Charles F Reynolds · University Of Pittsburgh At Pittsburgh · P30 · FY2012 · MH
Enhancing the efficacy of immunotherapy in DLBCL using rational combination approaches
$1,745,768Cheryl A London · Tufts University Boston · U01 · FY2017 · CA
Center for Lupus Research
$1,745,734Maria Virginia Pascual · Weill Medical Coll Of Cornell Univ · P50 · FY2019 · AR
Center for Lupus Research
$1,745,734Maria Virginia Pascual · Weill Medical Coll Of Cornell Univ · P50 · FY2021 · AR
Center for Lupus Research
$1,745,734Maria Virginia Pascual · Weill Medical Coll Of Cornell Univ · P50 · FY2020 · AR
Antibody Targeted Radiation and Immunotherapy for the Treatment of Solid Tumors
$1,745,671Andrew A. Raubitschek · Beckman Research Institute/City Of Hope · P01 · FY2011 · CA
Roswell Park Ovarian Cancer SPORE
$1,745,539Kirsten B Moysich · Roswell Park Cancer Institute Corp · P50 · FY2024 · CA
Clinical and Laboratory Studies of Malignant Lymphomas
$1,745,511Ronald Levy · Stanford University · P01 · FY2010 · CA
Signaling Processes Underlying Cardiovascular Function
$1,745,491Jeffrey Robbins · Cincinnati Childrens Hosp Med Ctr · P01 · FY2014 · HL
Immune Basis & Clinical implications of Threshold-Based Phenotypes of Peanut Allergy
$1,745,202Maria Cecilia Berin · Icahn School Of Medicine At Mount Sinai · U19 · FY2021 · AI
Center for AIDS Intervention Research Core Support
$1,745,185Jeffrey A. Kelly · Medical College Of Wisconsin · P30 · FY2015 · MH